NRG-BR002: A Randomized Phase II/III Trial of Metastases-Directed Ablation with First-Line Systemic Therapy for Oligometastatic Breast Cancer

ABSTRACT:

SUBMITTER: Chmura S 

PROVIDER: S-EPMC13647293 | biostudies-literature | 2026 Oct

REPOSITORIES: biostudies-literature